Imaging Technology

AUGUST 29, 2023

Administration of the therapeutic dose took place as part of an ongoing Phase I/IIa theranostic clinical trial conducted by Clarity Pharmaceuticals to investigate the safety and efficacy of Cu-67 SARTATE in pediatric patients with high-risk neuroblastoma.

Pharmaceutical 78

Pharmaceutical Radiopharmaceuticals Clinic Medical 78

Imaging Technology

JULY 5, 2023

Nucleus will use NorthStar’s Ac-225 for their customers’ radioligand pharmaceutical programs. Clinical research and commercial use of Ac-225 have been constrained by chronic short supply due to limitations of current production technology. President and Chief Executive Officer of NorthStar Medical Radioisotopes.

Medical 64

Medical Radiopharmaceuticals Pharmaceutical Radiation 64

Imaging Technology

APRIL 3, 2023

Mr. Merrick continued, “Demand for therapeutic radiopharmaceuticals is increasing rapidly. NorthStar has further deepened and broadened our business platform with the recent establishment of a full-scale radiopharmaceutical CDMO/CMO services unit. Ac-225 using advanced, environmentally preferable electron accelerator technology.

Medical 84

Medical Radiopharmaceuticals Pharmaceutical Radiation 84